D-Tyrosine

CAS No. 556-02-5

D-Tyrosine( —— )

Catalog No. M22478 CAS No. 556-02-5

D-Tyrosine negatively regulates melanin synthesis by inhibiting tyrosinase activity. D-Tyrosine is the D-isomer of tyrosine. D-Tyrosine inhibits biofilm formation and trigger the self-dispersal of biofilms without suppressing bacterial growth.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    D-Tyrosine
  • Note
    Research use only, not for human use.
  • Brief Description
    D-Tyrosine negatively regulates melanin synthesis by inhibiting tyrosinase activity. D-Tyrosine is the D-isomer of tyrosine. D-Tyrosine inhibits biofilm formation and trigger the self-dispersal of biofilms without suppressing bacterial growth.
  • Description
    D-Tyrosine negatively regulates melanin synthesis by inhibiting tyrosinase activity. D-Tyrosine is the D-isomer of tyrosine. D-Tyrosine inhibits biofilm formation and trigger the self-dispersal of biofilms without suppressing bacterial growth.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Tyrosinase
  • Recptor
    Tyrosinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    556-02-5
  • Formula Weight
    181.1
  • Molecular Formula
    C9H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?1M HCl : 25 mg/mL (137.98 mM)
  • SMILES
    N[C@H](Cc1ccc(O)cc1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Citraconic acid

    Citraconic acid is a dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position.

  • (Z)-SU14813

    (Z)-SU14813 is a novel tyrosine kinase inhibitor with anticardiogenic and antitumor activity that inhibits VEGFR-2, PDGFR-β, and FLT3 phosphorylation in xenograft tumors in a dose- and time-dependent manner.

  • 3-hydroxycephem

    3-hydroxycephem